feed,title,long_url,short_url
BioRxiv,NSP4 mutation T492I drives rapid evolution of SARS-CoV-2 toward Omicron,https://biorxiv.org/cgi/content/short/2024.07.05.602217v1?rss=1,https://da.gd/W4b85
BioRxiv,Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants,https://biorxiv.org/cgi/content/short/2024.07.08.602485v1?rss=1,https://da.gd/8qp0RP
